Literature DB >> 10601815

Maternal exposure to the synthetic cannabinoid HU-210: effects on the endocrine and immune systems of the adult male offspring.

I del Arco1, R Muñoz, F Rodríguez De Fonseca, L Escudero, J L Martín-Calderón, M Navarro, M A Villanúa.   

Abstract

Natural and synthetic cannabinoid receptor agonists have been described to exert profound effects on both the neuroendocrine integration and the functional responses of the immune system. In the present study, Wistar rats were exposed to the highly potent cannabinoid agonist HU-210 (1, 5 and 25 microg/kg) during gestation and lactation and the ensuing effects on several endocrine and immune parameters of the adult male offspring were analyzed. Perinatal exposure to HU-210 partially affected the distribution of lymphocyte subpopulations in the spleen and peripheral blood. The major changes observed occur after maternal exposure to the 25 microg/kg dose of HU-210. There was a reduction in the T-helper subpopulation in the spleen and a dose-related decrease in the rate of T(helper)/T(cytotoxic) in peripheral blood lymphocytes. Concanavalin-A and lipopolysaccharide-induced proliferation were normal in all the groups tested. In the same animals, perinatal exposure to HU-210 did not affect basal levels of growth hormone, IGF-1, prolactin, or follicle-stimulating hormone. Basal values of luteinizing hormone were elevated in animals given the 1 microg/kg dose of HU-210. Corticosterone levels were reduced in the animals exposed to the higher dose of HU-210 during gestation and lactation. These animals exhibited a decreased responsiveness of the hypothalamo-pituitary-adrenal (HPA) axis to the stimulation with a single injection of HU-210 (20 microg/kg, i.v.) at adult ages, which may reflect the onset of long-lasting tolerance to the HPA-activating properties of cannabinoids. The opposite pattern of response was found in the animals given the 1 microg/kg dose, in which a sensitization of the corticosterone response to acute HU-210 was observed. The present work reveals that maternal exposure to cannabinoids results in minor changes in the development of the immune system, but may induce long-lasting alterations in the functional status of the HPA axis. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10601815     DOI: 10.1159/000026416

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  14 in total

1.  Neurodevelopmental liabilities of substance abuse.

Authors:  Tomas Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

2.  Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.

Authors:  Catherine Lombard; Venkatesh L Hegde; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2011-08-10       Impact factor: 4.030

3.  Prenatal tobacco and marijuana co-use: Impact on newborn neurobehavior.

Authors:  Laura R Stroud; George D Papandonatos; Meaghan McCallum; Tessa Kehoe; Amy L Salisbury; Marilyn A Huestis
Journal:  Neurotoxicol Teratol       Date:  2018-09-26       Impact factor: 3.763

Review 4.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

5.  The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning.

Authors:  Nancy L Day; Sharon L Leech; Lidush Goldschmidt
Journal:  Neurotoxicol Teratol       Date:  2011 Jan-Feb       Impact factor: 3.763

Review 6.  Epigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in Offspring.

Authors:  Elizabeth E Zumbrun; Jessica M Sido; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-25       Impact factor: 4.147

7.  Prenatal tobacco and marijuana co-use: Sex-specific influences on infant cortisol stress response.

Authors:  Laura R Stroud; George D Papandonatos; Nancy C Jao; Chrystal Vergara-Lopez; Marilyn A Huestis; Amy L Salisbury
Journal:  Neurotoxicol Teratol       Date:  2020-04-11       Impact factor: 3.763

8.  Exposure to cannabinoids in the development of endogenous cannabinoid system.

Authors:  José A Ramos; Rosario De Miguel; Maribel Cebeira; Mariluz Hernandez; Javier Fernández-Ruiz
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

Review 9.  Cannabinoid exposure during pregnancy and its impact on immune function.

Authors:  Catherine Dong; Jingwen Chen; Amy Harrington; K Yaragudri Vinod; Muralidhar L Hegde; Venkatesh L Hegde
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

Review 10.  Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Authors:  Marisol S Castaneto; David A Gorelick; Nathalie A Desrosiers; Rebecca L Hartman; Sandrine Pirard; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2014-08-18       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.